BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34515762)

  • 1. PATHOME-Drug: a subpathway-based polypharmacology drug-repositioning method.
    Nam S; Lee S; Park S; Lee J; Park A; Kim YH; Park T
    Bioinformatics; 2022 Jan; 38(2):444-452. PubMed ID: 34515762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional therapeutic chemical classification system.
    Croset S; Overington JP; Rebholz-Schuhmann D
    Bioinformatics; 2014 Mar; 30(6):876-83. PubMed ID: 24177719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures.
    Namba S; Iwata M; Yamanishi Y
    Bioinformatics; 2022 Jun; 38(Suppl 1):i68-i76. PubMed ID: 35758779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gene2drug: a computational tool for pathway-based rational drug repositioning.
    Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
    Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.
    Jia Z; Liu Y; Guan N; Bo X; Luo Z; Barnes MR
    BMC Genomics; 2016 May; 17():414. PubMed ID: 27234029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Alignment of Ligand Binding Sites in Proteins for Polypharmacology and Drug Repositioning.
    Brylinski M
    Methods Mol Biol; 2017; 1611():109-122. PubMed ID: 28451975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm.
    Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y
    Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel computational approach for drug repurposing using systems biology.
    Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
    Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. deepDR: a network-based deep learning approach to in silico drug repositioning.
    Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F
    Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Oncology Drug Repositioning and Polypharmacology.
    Cheng F
    Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacology in Drug Development: A Minireview of Current Technologies.
    Tan Z; Chaudhai R; Zhang S
    ChemMedChem; 2016 Jun; 11(12):1211-8. PubMed ID: 27154144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods.
    Li Y; Yang Y; Tong Z; Wang Y; Mi Q; Bai M; Liang G; Li B; Shu K
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38647153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach.
    Madugula SS; Nagamani S; Jamir E; Priyadarsinee L; Sastry GN
    Mol Divers; 2022 Jun; 26(3):1675-1695. PubMed ID: 34468898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational polypharmacology: a new paradigm for drug discovery.
    Chaudhari R; Tan Z; Huang B; Zhang S
    Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
    Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
    BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repositioning by integrating target information through a heterogeneous network model.
    Wang W; Yang S; Zhang X; Li J
    Bioinformatics; 2014 Oct; 30(20):2923-30. PubMed ID: 24974205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GREP: genome for REPositioning drugs.
    Sakaue S; Okada Y
    Bioinformatics; 2019 Oct; 35(19):3821-3823. PubMed ID: 30859178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing.
    Chan J; Wang X; Turner JA; Baldwin NE; Gu J
    Bioinformatics; 2019 Aug; 35(16):2818-2826. PubMed ID: 30624606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug-drug links based on graph neural network.
    Cui C; Ding X; Wang D; Chen L; Xiao F; Xu T; Zheng M; Luo X; Jiang H; Chen K
    Bioinformatics; 2021 Sep; 37(18):2930-2937. PubMed ID: 33739367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.